Precision BioSciences (DTIL)
(Delayed Data from NSDQ)
$10.89 USD
-0.23 (-2.07%)
Updated Jun 17, 2024 03:59 PM ET
After-Market: $10.72 -0.17 (-1.56%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth C Momentum F VGM
Brokerage Reports
Precision BioSciences, Inc. [DTIL]
Reports for Purchase
Showing records 41 - 56 ( 56 total )
Company: Precision BioSciences, Inc.
Industry: Medical - Biomedical and Genetics
Getting Closer to Validation and Current $250M EV Offers Compelling Entry Points
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Precision BioSciences, Inc.
Industry: Medical - Biomedical and Genetics
One Becomes Two; PBCAR Clinical Family Has a Fresh Addition in Line WIth Prior Guidance
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Precision BioSciences, Inc.
Industry: Medical - Biomedical and Genetics
Awaiting Correlation Between Cell Dose and Outcomes; Target Lowered to $19
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Precision BioSciences, Inc.
Industry: Medical - Biomedical and Genetics
From TINA to Cash Is King and Other Musings
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Precision BioSciences, Inc.
Industry: Medical - Biomedical and Genetics
Bringing a Wallet to a Hammer and Sickle Fight, and Other Tidbits
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Precision BioSciences, Inc.
Industry: Medical - Biomedical and Genetics
Runners up Is the New Killing It, and Other Tidbits
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Precision BioSciences, Inc.
Industry: Medical - Biomedical and Genetics
Let?s Caucus, or Never Again; In an Otherwise Ho-Hum Earnings Week
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Precision BioSciences, Inc.
Industry: Medical - Biomedical and Genetics
With Allo CAR T''s Here to Stay, Protocol Amendments Are for the Better
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Precision BioSciences, Inc.
Industry: Medical - Biomedical and Genetics
2020 Catalyst Calendar and Top Picks Across Mid, Small, and Micro Caps
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Precision BioSciences, Inc.
Industry: Medical - Biomedical and Genetics
Our Thoughts Post ASH and Next Steps With a Preliminary Progress Report During 1Q20
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Precision BioSciences, Inc.
Industry: Medical - Biomedical and Genetics
3Q19 ASH Investor Event Remains a Meaningful Driver for the Shares
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Precision BioSciences, Inc.
Industry: Medical - Biomedical and Genetics
Intriguing First Look at Low Dose PBCAR019 in NHL
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Precision BioSciences, Inc.
Industry: Medical - Biomedical and Genetics
No Surprises: Quality and Health of T Cells Matter; PBCAR''s Might Be on to Something
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Precision BioSciences, Inc.
Industry: Medical - Biomedical and Genetics
One Becomes Two; PBCAR20a Set to Join PBCAR0191 in the Clinic
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Precision BioSciences, Inc.
Industry: Medical - Biomedical and Genetics
1H19 Update Looking Ahead to the First-in-Human Allo-CAR T Readout in r/r NHL
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Precision BioSciences, Inc.
Industry: Medical - Biomedical and Genetics
We initiate Precision with a Buy rating and $21 target.
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D